| Abt-737 | IC50 | 1.0 [1], 6.1 [2], 7.0 [3], 20.0 [4] |
| Abt-737 | Ki | 1.0 [1] |
| Gossypol | IC50 | 260.0 [1], 500.0 [2], 600.0 [3], 2110.0 [4] |
| Gossypol | Ki | 420.0 [1], 440.0 [2], 450.0 [3], 511.0 [4] |
| Venetoclax | IC50 | 7.39 [1], 7.4 [2] |
| Venetoclax | Ki | 0.01 [1], 0.04 [2], 1.0 [3] |
| Navitoclax | IC50 | 10.3 [1], 15.0 [2] |
| Navitoclax | Ki | 0.04 [1], 1.0 [2] |
| 8-Oxo-3-thiomorpholino-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile | IC50 | 285.0 [1], 715.0 [2] |
| 8-Oxo-3-thiomorpholino-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile | Ki | 310.0 [1], 319.0 [2] |
| (2S)-N-(4-Methylphenyl)sulfonyl-2-[(5Z)-4-oxo-5-[(4-phenylphenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-3-yl]-3-phenylpropanamide | Ki | 500.0 [1], 620.0 [2], 660.0 [3], 760.0 [4], 940.0 [5] |
| N-[4-(2-Tert-Butylphenylsulfonyl)phenyl]-2,3,4-trihydroxy-5-(2-isopropylbenzyl)benzamide | IC50 | 200.0 [1], 700.0 [2] |
| N-[4-(2-Tert-Butylphenylsulfonyl)phenyl]-2,3,4-trihydroxy-5-(2-isopropylbenzyl)benzamide | Ki | 290.0 [1], 300.0 [2] |
| 2,3,4-Trihydroxy-5-isopropyl-N-phenyl-benzamide | IC50 | 7000.0 [1], 53100.0 [2] |
| 2,3,4-Trihydroxy-5-isopropyl-N-phenyl-benzamide | Ki | 24100.0 [1], 31900.0 [2] |
| Antimycin A3 | IC50 | 2000.0 [1] |
| Antimycin A3 | Ki | 831.76 [1], 124000.0 [2] |
| 4-(4-Fluorophenyl)-N-[3-nitro-4-(2-phenylsulfanylethylamino)phenyl]sulfonylbenzamide | IC50 | 93.0 [1], 6300.0 [2] |
| 4-(4-Fluorophenyl)-N-[3-nitro-4-(2-phenylsulfanylethylamino)phenyl]sulfonylbenzamide | Ki | 433.0 [1] |
| N-[4-[[(2R)-4-(Dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonyl-4-(4,4-dimethylpiperidin-1-yl)benzamide | Ki | 62.0 [1], 67.0 [2] |
| 4-[8-Ethylsulfanyl-3-(4-hydroxyphenyl)-3-methyloctan-4-yl]phenol | IC50 | 9000.0 [1] |
| 4-[8-Ethylsulfanyl-3-(4-hydroxyphenyl)-3-methyloctan-4-yl]phenol | Ki | 169000.0 [1], 254000.0 [2] |
| 5-Benzyl-2-(5-benzyl-1,4,6,7-tetrahydroxy-3-methylnaphthalen-2-yl)-3-methylnaphthalene-1,4,6,7-tetrone | IC50 | 31.0 [1], 290.0 [2] |
| 5-Benzyl-2-(5-benzyl-1,4,6,7-tetrahydroxy-3-methylnaphthalen-2-yl)-3-methylnaphthalene-1,4,6,7-tetrone | Ki | 190.0 [1] |
| (3,4-Dihydroisoquinolin-2(1H)-yl)(2,3,4-trihydroxy-5-isopropylphenyl)methanone | IC50 | 38200.0 [1] |
| (3,4-Dihydroisoquinolin-2(1H)-yl)(2,3,4-trihydroxy-5-isopropylphenyl)methanone | Ki | 3100.0 [1] |
| N-Phenyl-2,3,4-trihydroxy-5-benzyl-benzamide | IC50 | 5000.0 [1], 7200.0 [2] |
| N-Phenyl-2,3,4-trihydroxy-5-benzyl-benzamide | Ki | 8300.0 [1] |
| N-[4-(Benzenesulfonyl)phenyl]-5-benzyl-2,3,4-trihydroxybenzamide | IC50 | 1600.0 [1], 4000.0 [2] |
| N-[4-(Benzenesulfonyl)phenyl]-5-benzyl-2,3,4-trihydroxybenzamide | Ki | 930.0 [1] |
| (-)-Epicatechin | Ki | 100000.0 [1] |
| (-)-Epigallocatechin gallate | Ki | 234.42 [1], 335.0 [2] |
| Epigallocatechin | Ki | 100000.0 [1] |
| (-)-Epicatechin gallate | Ki | 229.09 [1], 400.0 [2] |
| (2Z)-2-[(5Z)-5-[(3,5-Dimethyl-1H-pyrrol-2-yl)methylidene]-4-methoxypyrrol-2-ylidene]indole | IC50 | 1110.0 [1] |
| L-Epicatechin | Ki | 100000.0 [1] |
| Apogossypolone | IC50 | 370.0 [1] |
| Apogossypolone | Ki | 250.0 [1] |
| Apogossypol | IC50 | 80000.0 [1] |
| Apogossypol | Ki | 2800.0 [1] |
| 2,3,5-Trihydroxy-7-methyl-N-(2-phenylpropyl)-6-[1,6,7-trihydroxy-3-methyl-5-(2-phenylpropylcarbamoyl)naphthalen-2-yl]naphthalene-1-carboxamide | IC50 | 320.0 [1], 660.0 [2] |
| Nvp-cgm097 | IC50 | 50000.0 [1] |
| CID 59447577 | Ki | 74.0 [1], 80.0 [2] |
| Anthragallol | Ki | 583.0 [1], 1325.0 [2] |
| 2-[5-(4-Bromobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl]-3-phenylpropanoic acid | Ki | 14200.0 [1] |
| Isopropyl-3-(4-isopropylphenoxy)-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile | IC50 | 739.0 [1] |
| Isopropyl-3-(4-isopropylphenoxy)-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile | Ki | 252.0 [1] |
| 5-(4-Chlorophenyl)-4-[3-[4-[4-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylamino]phenyl]piperazin-1-yl]phenyl]-1,2-dimethylpyrrole-3-carboxylic acid | IC50 | 1.3 [1] |
| 5-(4-Chlorophenyl)-4-[3-[4-[4-[[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylamino]phenyl]piperazin-1-yl]phenyl]-1,2-dimethylpyrrole-3-carboxylic acid | Ki | 1.0 [1] |
| 3,4,5-Trihydroxy-1,8-bis[(2R,3R)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-2-yl]benzo[7]annulen-6-one | Ki | 690.0 [1], 691.83 [2] |
| 3-(4-Aminophenylthio)-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile | IC50 | 302.0 [1], 331.0 [2] |
| 4-Benzamido-N-[3-nitro-4-(2-phenylsulfanylethylamino)phenyl]sulfonylbenzamide | Ki | 1670.0 [1], 1700.0 [2] |
| 5-(4-Chlorophenyl)-1-ethyl-4-[3-[4-[4-[[4-[[(2R)-4-(4-hydroxypiperidin-1-yl)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylamino]phenyl]piperazin-1-yl]phenyl]-2-methylpyrrole-3-carboxylic acid | IC50 | 5.4 [1] |
| 5-(4-Chlorophenyl)-1-ethyl-4-[3-[4-[4-[[4-[[(2R)-4-(4-hydroxypiperidin-1-yl)-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylamino]phenyl]piperazin-1-yl]phenyl]-2-methylpyrrole-3-carboxylic acid | Ki | 1.2 [1] |
| N-(2-Phenylethyl)-2-[2,3,4-trihydroxy-5-[methyl(3-phenylpropyl)sulfamoyl]benzoyl]-3,4-dihydro-1H-isoquinoline-7-sulfonamide | IC50 | 330.0 [1] |
| N-(2-Phenylethyl)-2-[2,3,4-trihydroxy-5-[methyl(3-phenylpropyl)sulfamoyl]benzoyl]-3,4-dihydro-1H-isoquinoline-7-sulfonamide | Ki | 110.0 [1] |
| 4-[4-[[2-(4-Chlorophenyl)-6-[2-(dimethylamino)-2-oxoethoxy]phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide | IC50 | 10.0 [1], 45.0 [2] |
| 4-[4-[[2-(4-Chlorophenyl)-5-[2-(dimethylamino)-2-oxoethoxy]phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide | IC50 | 10.0 [1], 187.0 [2] |
| 4-[4-[[2-(4-Chlorophenyl)-6-[2-(dimethylamino)ethoxy]phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide | IC50 | 4.0 [1], 10.0 [2] |
| 4-[4-[[2-(4-Chlorophenyl)-5-[2-(dimethylamino)ethoxy]phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide | IC50 | 10.0 [1], 22.0 [2] |
| 2-[4-[[2-(4-Chlorophenyl)phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylpyrimidine-5-carboxamide | IC50 | 18.0 [1], 340.0 [2] |
| 4-[4-[(R)-[2-(4-Chlorophenyl)phenyl]sulfinyl]piperidin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide | IC50 | 19.0 [1], 434.0 [2] |
| 4-[4-[[2-(4-Chlorophenyl)phenyl]methyl]-4-cyanopiperidin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide | IC50 | 10.0 [1], 545.0 [2] |
| 1-(4-Phenoxyphenyl)-4-[(4-propan-2-yloxybenzoyl)amino]-5-(4-propan-2-yloxyphenyl)pyrazole-3-carboxylic acid | IC50 | 5000.0 [1] |
| 1-(4-Phenoxyphenyl)-4-[(4-propan-2-yloxybenzoyl)amino]-5-(4-propan-2-yloxyphenyl)pyrazole-3-carboxylic acid | Ki | 140.0 [1] |
| (5Z)-2,9-Dimethoxy-5,6-dioxido-11,12-dihydrobenzo[c][1,2]benzodiazocine-5,6-diium | IC50 | 4000.0 [1], 10400.0 [2] |
| N-[2-(4-Ethylphenyl)ethyl]-6-[5-[2-(4-ethylphenyl)ethylcarbamoyl]-3-methyl-1,4,6,7-tetraoxonaphthalen-2-yl]-2,3,5,8-tetrahydroxy-7-methylnaphthalene-1-carboxamide | IC50 | 210.0 [1] |
| N-[2-(4-Ethylphenyl)ethyl]-6-[5-[2-(4-ethylphenyl)ethylcarbamoyl]-3-methyl-1,4,6,7-tetraoxonaphthalen-2-yl]-2,3,5,8-tetrahydroxy-7-methylnaphthalene-1-carboxamide | Ki | 140.0 [1] |
| 3-Methyl-5-(2-phenylacetyl)-2-[1,4,6,7-tetrahydroxy-3-methyl-5-(2-phenylacetyl)naphthalen-2-yl]naphthalene-1,4,6,7-tetrone | IC50 | 220.0 [1] |
| 3-Methyl-5-(2-phenylacetyl)-2-[1,4,6,7-tetrahydroxy-3-methyl-5-(2-phenylacetyl)naphthalen-2-yl]naphthalene-1,4,6,7-tetrone | Ki | 150.0 [1] |
| 2,3,5,8-Tetrahydroxy-7-methyl-6-[3-methyl-1,4,6,7-tetraoxo-5-(2-phenylpropylcarbamoyl)naphthalen-2-yl]-N-(2-phenylpropyl)naphthalene-1-carboxamide | IC50 | 230.0 [1] |
| 2,3,5,8-Tetrahydroxy-7-methyl-6-[3-methyl-1,4,6,7-tetraoxo-5-(2-phenylpropylcarbamoyl)naphthalen-2-yl]-N-(2-phenylpropyl)naphthalene-1-carboxamide | Ki | 150.0 [1] |
| 5-(Cyclopentylmethyl)-2-[5-(cyclopentylmethyl)-1,4,6,7-tetrahydroxy-3-methylnaphthalen-2-yl]-3-methylnaphthalene-1,4,6,7-tetrone | IC50 | 2270.0 [1] |
| 5-(Cyclopentylmethyl)-2-[5-(cyclopentylmethyl)-1,4,6,7-tetrahydroxy-3-methylnaphthalen-2-yl]-3-methylnaphthalene-1,4,6,7-tetrone | Ki | 1530.0 [1] |
| 5-(2-Cyclohexylethyl)-2-[5-(2-cyclohexylethyl)-1,4,6,7-tetrahydroxy-3-methylnaphthalen-2-yl]-3-methylnaphthalene-1,4,6,7-tetrone | IC50 | 6730.0 [1] |
| 5-(2-Cyclohexylethyl)-2-[5-(2-cyclohexylethyl)-1,4,6,7-tetrahydroxy-3-methylnaphthalen-2-yl]-3-methylnaphthalene-1,4,6,7-tetrone | Ki | 4470.0 [1] |
| 3-Methyl-5-(2-phenylethyl)-2-[1,4,6,7-tetrahydroxy-3-methyl-5-(2-phenylethyl)naphthalen-2-yl]naphthalene-1,4,6,7-tetrone | IC50 | 2570.0 [1] |
| 3-Methyl-5-(2-phenylethyl)-2-[1,4,6,7-tetrahydroxy-3-methyl-5-(2-phenylethyl)naphthalen-2-yl]naphthalene-1,4,6,7-tetrone | Ki | 1730.0 [1] |
| 5-[(4-Chlorophenyl)methyl]-2-[5-[(4-chlorophenyl)methyl]-1,4,6,7-tetrahydroxy-3-methylnaphthalen-2-yl]-3-methylnaphthalene-1,4,6,7-tetrone | IC50 | 340.0 [1] |
| 5-[(4-Chlorophenyl)methyl]-2-[5-[(4-chlorophenyl)methyl]-1,4,6,7-tetrahydroxy-3-methylnaphthalen-2-yl]-3-methylnaphthalene-1,4,6,7-tetrone | Ki | 230.0 [1] |
| 3-Methyl-5-(2-methylpropyl)-2-[1,4,6,7-tetrahydroxy-3-methyl-5-(2-methylpropyl)naphthalen-2-yl]naphthalene-1,4,6,7-tetrone | IC50 | 250.0 [1] |
| 3-Methyl-5-(2-methylpropyl)-2-[1,4,6,7-tetrahydroxy-3-methyl-5-(2-methylpropyl)naphthalen-2-yl]naphthalene-1,4,6,7-tetrone | Ki | 170.0 [1] |
| 3-Methyl-5-[2-(4-methylphenyl)ethyl]-2-[1,4,6,7-tetrahydroxy-3-methyl-5-[2-(4-methylphenyl)ethyl]naphthalen-2-yl]naphthalene-1,4,6,7-tetrone | IC50 | 3120.0 [1] |
| 3-Methyl-5-[2-(4-methylphenyl)ethyl]-2-[1,4,6,7-tetrahydroxy-3-methyl-5-[2-(4-methylphenyl)ethyl]naphthalen-2-yl]naphthalene-1,4,6,7-tetrone | Ki | 2080.0 [1] |
| 3-Methyl-5-(3-phenylpropyl)-2-[1,4,6,7-tetrahydroxy-3-methyl-5-(3-phenylpropyl)naphthalen-2-yl]naphthalene-1,4,6,7-tetrone | IC50 | 2170.0 [1] |
| 3-Methyl-5-(3-phenylpropyl)-2-[1,4,6,7-tetrahydroxy-3-methyl-5-(3-phenylpropyl)naphthalen-2-yl]naphthalene-1,4,6,7-tetrone | Ki | 1450.0 [1] |
| N-[4-(2-Tert-butylphenyl)sulfonylphenyl]-2,3,4-trimethoxy-5-[(2-propan-2-ylphenyl)methyl]benzamide | IC50 | 100000.0 [1] |
| N-[4-(2-Tert-butylphenyl)sulfonylphenyl]-2,3,4-trimethoxy-5-[(2-propan-2-ylphenyl)methyl]benzamide | Ki | 25000.0 [1] |
| N-(2-Phenylethyl)-2-(2,3,4-trihydroxy-5-propan-2-ylbenzoyl)-3,4-dihydro-1H-isoquinoline-7-sulfonamide | IC50 | 6600.0 [1] |
| N-(2-Phenylethyl)-2-(2,3,4-trihydroxy-5-propan-2-ylbenzoyl)-3,4-dihydro-1H-isoquinoline-7-sulfonamide | Ki | 590.0 [1] |
| 1-[2-[(3S)-3-(Aminomethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-4-chloro-5-methyl-N,N-diphenylpyrazole-3-carboxamide | IC50 | 30.0 [1], 100.0 [2] |
| 4-[4-[[2-(4-Chlorophenyl)phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide | IC50 | 11.0 [1], 14.0 [2] |
| N,N-Dibutyl-1-[2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-5-methylpyrazole-3-carboxamide | IC50 | 230.0 [1], 2010.0 [2] |
| N,N-Dibutyl-4-chloro-1-[2-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide | IC50 | 100.0 [1], 780.0 [2] |
| 4-Bromo-1-[2-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide | IC50 | 40.0 [1], 210.0 [2] |
| 4-Chloro-1-[2-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methyl-N,N-diphenylpyrazole-3-carboxamide | IC50 | 50.0 [1], 480.0 [2] |
| 4-Bromo-N,N-diethyl-1-[2-[(3S)-3-(hydroxymethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-5-methylpyrazole-3-carboxamide | IC50 | 3670.0 [1], 17300.0 [2] |
| 1-[2-[(3S)-3-(Aminomethyl)-3,4-dihydro-1H-isoquinoline-2-carbonyl]phenyl]-N,N-dibutyl-4-chloro-5-methylpyrazole-3-carboxamide | IC50 | 20.0 [1], 160.0 [2] |
| 1-[4-Amino-2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-N,N-dibutyl-4-chloro-5-methylpyrazole-3-carboxamide | IC50 | 90.0 [1], 700.0 [2] |
| 1-[4-Benzamido-2-(3,4-dihydro-1H-isoquinoline-2-carbonyl)phenyl]-N,N-dibutyl-4-chloro-5-methylpyrazole-3-carboxamide | IC50 | 810.0 [1], 5660.0 [2] |